1. terrasig
  2. Be Careful Making "Drug" Claims...

Be Careful Making "Drug" Claims...

By terrasig on October 16, 2007.

These aren't the 1920s. If you want to get your remedy approved as a drug, you've got to abide by the rules everyone else plays by. From the FDA press release:

At FDA's request, U.S. marshals have seized about $71,000 worth of products from Florida-based FulLife Natural Options Inc. after the agency determined that FulLife violated food and drug law by promoting certain products for use in treating serious conditions such as diabetes and high blood pressure. Because of the claims, FDA considers the products -- Charantea Ampalaya Capsules and Charantea Ampalaya Tea -- to be unapproved drugs.

Cluestick to unscrupulous manufacturers who make it bad for the reputable folks: stay away from chronic and potentially fatal diseases...and re-read the label claims section of DSHEA.

Tags
Non-herbal supplements

More like this

Finally, the Department of Justice and FDA go after unsafe supplements in a big way
Now that's what I'm talking about! Yesterday, the Justice Department announced criminal charges and lawsuits against the sellers of several supplements! This is the ort of thing that is long overdue—incredibly so, in fact. Before I get to this specific case, let's discuss a little background. One…
The wonderfully Orwellian Free Speech About Science Act of 2011 (H.R. 1364)
"Health freedom." It's a battle cry frequently used by supporters of "alternative" medicine against what they perceive to be persecution by the medical and scientific establishment that uses the Food and Drug Administration, the Federal Trade Commission, and other federal agencies charged with…
"Cherry-pickers" issued permanent injunction by FDA
From today's FDA Digest comes the following notice of action: The U.S. Food and Drug Administration today announced that Brownwood Acres Foods Inc., Cherry Capital Services Inc. (doing business as Flavonoid Sciences) and two of their top executives have signed a consent decree that effectively…
Big pharma wins a battle on off-label prescribing
There's a phenomenon known as off-label prescribing. Basically, to prescribe something off-label is to prescribe it for an indication that is not FDA-approved but that is supported by considerable evidence. For example, it could involve using an FDA-approved drug for an indication that is not…

I don't get it. These companies have virtually unregulated free reign in the supplement market with minimal overhead costs relative to a pharma co. Why would they jeopardize profits by making direct disease treatment claims?

This dovetails nicely with the article I emailed you.

I live in Portland, at the heart of CAM country. I am working on an article that I hope to get published in a local paper here, that is sure to draw serious fire from CAM practitioners and instructors. Thanks for providing so much great info to help me get my ducks in a row on this topic.